Troy Edward Wilson Puma Biotechnology, Inc. (PBYI) insider trading activity

Troy Edward Wilson is Director of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 43,550 shares of PBYI, which is worth approximately $148,505. The most recent transaction as insider was on Jun 13, 2025, when has been sold 10,800 shares (Common Stock) at a price of $3.4 per share, resulting in proceeds of $36,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.6K

59.23% 3M change

59.23% 12M change

Total Value Held $148,505

TROY EDWARD WILSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2025	SELL Open market or private sale	$36,720 $3.4 p/Share	10,800 Reduced 19.87%	43,550 Common Stock
Jun 11 2025	BUY Grant, award, or other acquisition	-	27,000 Added 33.19%	54,350 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	27,000 Added 49.68%	27,350 Common Stock
Jun 13 2024	SELL Open market or private sale	$89,910 $3.33 p/Share	27,000 Reduced 98.72%	350 Common Stock
Jun 13 2023	SELL Open market or private sale	$93,150 $3.45 p/Share	27,000 Reduced 98.72%	350 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	27,000 Added 49.68%	27,350 Common Stock
Jun 16 2022	SELL Open market or private sale	$71,874 $2.58 p/Share	27,858 Reduced 50.46%	27,350 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	27,000 Added 32.84%	55,208 Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	27,858 Added 49.69%	28,208 Common Stock
Jun 10 2021	SELL Open market or private sale	$292,497 $11.36 p/Share	25,748 Reduced 98.66%	350 Common Stock

Also insider at

KURA

Kura Oncology, Inc. Healthcare

President and CEO

RNA

Avidity Biosciences, Inc. Healthcare

Director

TEW